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ABSTRACT
Despite the significant improvements made to address addiction and drug
diversion by healthcare personnel, the issue continues to be problematic for most
healthcare facilities. Current literature suggests that healthcare institutions incorporate
early drug diversion and addiction education, implementation of effective policies and
procedures, and continuous drug screening will strongly aid in decreasing the prevalence
of drug diversion by healthcare providers.
Among all the different types of healthcare providers, anesthesia providers
continue to be at a disproportionately higher risk for addiction and drug diversion when
compared to other providers (AANA, 2016). The stress of a demanding profession,
personality, and easy access to addictive medications all play a part in this statistic, thus,
are responsible for the increased risk of addiction and drug diverting by anesthesia
providers (Wright et al., 2012). The disease of addiction and the act of drug diversion is
a multifaceted problem that affects the healthcare provider, coworkers, hospitals, patients,
and families. Therefore, it is imperative that healthcare institutions have policies and
procedures in place that comply with current best practice guidelines regarding employee
drug diversion. The purpose of this DNP project was to perform a policy analysis on the
institution of interest drug diversion reporting and response policy. A SWOT analysis
was performed and after a thorough review of the evidence, a set of best practice
guidelines regarding a drug diversion policy were used to compare the participating
facility’s current policy for reporting drug diversion in an employee. An executive
summary of policy analysis findings and suggested revisions to the institution’s current
policy was presented to the key participants.
ii
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CHAPTER I - INTRODUCTION
Substance abuse is a topic of concern in the practice of Certified Registered Nurse
Anesthetist (CRNA). According to the American Association of Nurse Anesthetist
(AANA, 2015), 1 out of every 10 CRNAs is misusing drugs within the workplace.
Substance abuse, thus addiction, is an illness that is difficult to understand and is a
disease that spans our entire economic and social spectrum (AANA, 2015). A term
associated with substance abuse is drug diversion. For the purpose of this project, “drug
diversion” is used in reference to the act of a healthcare provider redirecting drugs for
personal use both on and off duty (AANA 2016). Drug diversion is a considerable
problem in healthcare facilities around the world (Bell, McDonough, Ellison, & Fitzhugh,
1999). Substance abuse and drug diversion in the workplace is an issue that must never
be ignored because of its importance to both patient and provider safety. An impaired
provider, specifically the CRNA profession, who is diverting drugs cannot deliver safe
anesthesia or respond to an emergency appropriately, thus placing the patient in harm’s
way (AANA, 2015). Review of evidence reveals that within healthcare institutions, early
education, vigorous programs, effective processes, and the continuous use of screening
can aid in decreasing the prevalence of substance abuse and drug diversion among
healthcare professionals (AANA, 2015).
Background and Significance
Anesthesia providers are at a disproportionately higher risk for substance abuse
when compared to other healthcare professionals (Wright et al., 2012). A variety of
reasons, including the stress of a demanding profession, personality traits among CRNAs
and access to highly addictive medications, are responsible for the increased statistics
9

among anesthesia providers Wright et al., 2012). It is estimated that 10-20% of nurse
anesthetists will experience some form of drug misuse during their career (Bell et al.,
1999). Chemical dependency in an anesthesia provider occurs most frequently in the first
five years of practice, according to the fact sheet provided by AANA (2015). If that
statistic was not alarming enough, Tetzlaff (2011), stated the leading cause of death
among young anesthesia providers is substance abuse. Despite the alarming statistics,
many would argue the statistics are “off” or “not accurate” due to the difficulty it is to
obtain the accurate frequency of substance abuse and drug diversion, not only among
anesthesia providers but in healthcare providers as a whole (Wright et al., 2012). Legal
issues, risk of losing licensure, policy, and processes in place by institutions and patient
safety, all play a role in obtaining accurate data pertaining to confirmed substance abuse
and/or drug diversion by healthcare personnel, thus, making this problem more likely
larger than we know (Wright et al., 2012).
The AANA acknowledges the risk anesthesia providers face and in 1984, the
AANA adopted the AANA Position Statement 1.7 Chemical Dependency. The position
statement has since been revised to the AANA Position Statement 1.7 Substance Misuse
and Chemical Dependency. Over the years, the AANA has continued to recognize the
disease of addiction and what it means for the anesthesia community. AANA has
developed multiple wellness programs and Peer Assistance Advisors (PAA) groups in
every state that provide 24-hour phone hotline service for those in need. The American
Nurses Association (Strobbe & Crowley, 2017) has also taken a stance against nursing
impairment and defines it as a “nurse who is unable to meet the requirements of the
Professional code of ethics established by the ANA as a result of cognitive, interpersonal
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or psychomotor dysfunction from excessive use of alcohol or drugs” (p. 105). Seventy
percent of all disciplinary cases addressed by the state board of nursing are related to the
chemically impaired nurse (National Council of State Boards of Nursing [NCSBN]),
2011).
Substance abuse and the disease of addiction not only affects the healthcare
provider but, also, the patients who have entrusted the provider to keep them safe
(Kunyk, 2015). Abuse among healthcare providers is often not recognized until death or
a near-death overdose has occurred (ANA, 2015). Because of this fact, it is crucial that
every institution have policy and prevention programs in place to prevent, detect, report
and respond to drug diversion (AANA, 2016). The American Nurse Association (ANA,
2015) educates that in addition to nurses and advanced practice nurses, ancillary staff
may also have access to medications, thus, providing an opportunity for the diversion of
drugs. Warner et al. (2015) reported on a surgical technician who diverted opioids by
replacing fentanyl syringes with syringes filled with saline that were now contaminated.
In this report by Warner et al. (2015), an unknown number of patients were exposed to
hepatitis C, but 18 patients were confirmed to be infected with the virus.
Best practice guidelines regarding drug diversion policy emphasize the
importance of facilities to have clear and specific policies in place for drug diversion in
the workplace. Processes and procedures that include early education, drug diversion
programs, clear guidelines for reporting diversion, effective management of confirmed
diversion and the transition to treatment are all key steps in the prevention of adverse
outcomes related to drug diversion (AANA, 2016). Policies that advocate for fair and
uniform management help create the safe environment for “prompt reporting, appropriate
11

treatment, and the potential for reentry of the professional into clinical practice” (Lien,
2012, p. 607). Therefore, it is important to determine the most effective ways to decrease
the risk of substance abuse and drug diversion among all healthcare providers, including
students who are utilizing hospitals for clinical gain. Chronic stress places the anesthesia
students at an increased risk for illness, injury to self and substance abuse (Bozimowski,
Groh, Rouen, & Dosch, 2014). The AANA (2015) believes the lack of SRNA education
related to effective coping skills and recognizing the signs and symptoms of risky
behaviors can contribute to this problem. There are multiple risk factors that contribute
to the risk of substance abuse as a provider, but stress is a precursor in anesthesia
programs and in the early years of practicing (Bozimowski et al., 2014). Healthcare
facilities, administration, and nursing programs have a responsibility to ensure that the
processes, policy, and security systems are in place to prevent drug diversion and to
protect patients if impairment is suspected (ANA, 2015).
Problem Statement
Anesthesia providers are often in contact with controlled substances. The
progression of substance abuse is rapid and coupled with a very high morbidity and
mortality rate (Tetzlaff, 2011). Substance abuse and drug diversion is a multifaceted
problem that affects providers, co-workers, employers, patients and families (Berge,
Dillon, Sikkink, Taylor, & Lanier, 2012). The AANA (2016) estimates diversion and
addiction of anesthesia providers at greater than 15%. The ANA (2015) estimates that 68% of nurses use alcohol or drugs to the extent that it impairs professional performance.
The impaired provider poses a significant threat not only to patient safety but also
become a liability to the health care institutions and departments where the diversion
12

occurred. (ANA, 2015). The clinical question for this DNP project asks, Does the drug
diversion policy at a Level II hospital in southeast Mississippi follow best practice
guidelines regarding healthcare employees?
Purpose of Project
The purpose of this DNP project was to perform a policy analysis on the drug
diversion reporting and response policy at a local hospital. Clear policies and procedures
should be set in place for dealing with such investigations and managing the many
possible outcomes of a confirmed diversion. The policy was compared to current best
practice guidelines for drug diversion policies and prevention within healthcare facilities.
The student developed a new language for the policy related to suspected or confirmed
drug diversion in student registered nurse anesthetists. Educational modules were also
developed for the local facility and anesthesia program to utilize as part of their efforts to
decrease the incidence of drug diversion amongst present and future anesthesia providers.
Needs Assessment
A needs assessment was performed and a gap in the current drug diversion policy,
when compared to the best practice guidelines at a local hospital, was found. The drug
diversion policy at the local facility in south Mississippi lacked the appropriate language
needed in their policy related to the impaired anesthesia student. In the policy, there is a
gap in terms of what supervisors and managers do for their employees which are not
appropriate for the student and academic partners dealing with a drug diversion incident.
The facility of interest was asked to provide a policy, based on best practice guidelines,
specifically related to drug diversion in student registered nurse anesthetists. Also, a
complete analysis was performed on the drug diversion reporting and response policy and
13

compared to best practice guidelines. Thus, the policy problem question addressed the
enhancements needed in the policy so that it meets all best practice guidelines suggested
for an effective drug diversion policy. Evaluation of the gaps between the current
evidence and the current policy at the local hospital was also performed. Collaboration
between all parties involved, but specifically, the hospital and the university, are
necessary for effective action to be taken when drug diversion is confirmed in a student.
Theoretical Framework
The model that aided in the policy analysis is Bardach's model. Bardach's model
recommends summarizing the policy issues, evaluating the supporting and opposing
arguments, analysis of stakeholders and anticipated impact on sentinel outcomes. There
are eight steps included in Bardach's model. The eight steps include: define the problem,
assemble the evidence, construct the evidence, select the criteria, project the outcomes
confront the tradeoffs, decide and finally, and tell your story. Steps one through four
focus on framing the analysis, while steps five through eight emphasize actually doing
the analysis and disseminating findings. The impact on outcomes, according to Bardach's
model, includes evaluating population health benefits, costs, and equity and
administrative feasibility. The “tell your story” stage of Bardach's model, culminates
with the presentation of findings to key internal stakeholders at the local hospital that
includes the policy analysis and evaluation with recommendations for policy changes
within the hospital, an algorithmic plan for reporting drug diversion in SRNAs and
educational modules.

14

DNP Essentials
There are eight essential elements of the Doctor of Nursing Practice (DNP) degree
(AACN, 2006). Each of those eight essentials were met in the development of this
project and are listed as follows:
Essential I: Scientific Underpinnings for Practice
Essential one was met by completing an evidence review of the topic, exploring
the scientific knowledge previously discovered. The evidence discovered will aid in
developing best practice guidelines for a drug diversion policy.
Essential II: Organizational and Systems Leadership for Quality Improvement and
Systems Thinking
Essential II focuses on quality improvement and systems thinking, which was met
by performing a policy analysis, along with the development of educational modules.
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice
Essential III was met through an integrated review of evidence and analysis of the
best practice guidelines for drug diversion policy in healthcare institutions.
Essential IV: Information Systems/Technology and Patient Care Technology for the
Improvement and Transformation of Health Care
Information systems and technology was utilized by formatting a policy algorithm
used as part of improving the drug diversion reporting and response policy at the facility
of interest.
Essential V: Health Care Policy for Advocacy in Health Care
Essential V was met by analyzing the current drug diversion policy at the hospital
of interest as means to update policy to meet demands by best practice guidelines.
15

Essential VI: Interprofessional Collaboration for Improving Patient and Population
Health Outcomes
Continuous collaboration with hospital research committee, anesthesia and
pharmacy departments necessary for the success of this DNP project targeted outcome,
Essential VI was met.
Essential VII: Clinical Prevention and Population Health for Improving the Nation’s
Health
Essential VII was met through a policy analysis performed and the development
of education modules on addiction and drug diversion. The modules will be used as a
way to bring drug diversion awareness to all hospital employees and students.
Essential VII: Advanced Nursing Practice
The analysis of evidence, synthesis of data, presentation of findings and the
assessment of the impact of the information presented to key stakeholders are all
expected of the advanced practice nurse, therefore this essential was met.
Review of the Evidence
An evidence search was performed to explore the best practice guidelines for drug
diversion policies and procedures in healthcare facilities. A secondary search was done
to explore the disease of addiction, signs, and symptoms of drug diversion, available
resources, and best practice prevention guidelines. Several databases including CINAHL
with Full Text, Medline, PubMed, Cochrane, and Google Scholar were searched for
relevant articles. The following search terms were utilized: addiction, drug diversion,
anesthesia, substance abuse, impaired provider. An initial search with limitations to full
text only and publication dates between 2000 and 2016 returned 114 articles after
16

duplications were removed. Upon further review of all databases accessed, 10 articles
were selected because they were strongly applicable to this project. An evidence matrix
is included with information from each of the included articles (See Appendix B).
Addiction is a Disease
Our nation is in the midst of an unprecedented opioid epidemic (U. S. Department
of Health & Human Services, 2016). On an average day in the United States, 3,900
people initiate a nonmedical use of opioids (MSDH.ms.gov). In the state of Mississippi
alone, 3.3 million opioid prescriptions were dispensed in 2016 (MSDH.ms.gov). On
average, for every Mississippi resident, there were 2.4 allocated for controlled substances
and 1.1 prescriptions for opioid analgesics during 2016 (MSDH.ms.gov).
Substance-use disorder (SUD) is the diagnostic term in the fifth edition of the
Diagnostic and Statistical Manual of Mental Disorders referring to the recurrent use of
alcohol or other drugs that causes clinically and functionally significant impairment
(Substance Abuse and Mental Health Services Administration (SAMHSA, 2017). The
impairment is so significant, individuals are unable to meet the responsibilities at work,
school or home that they once were able to do. Substance use disorders are
neurobiological disorders, they are not a choice to abuse or become dependent on a
substance (SAMHSA, 2017). Once someone is addicted, there is a complete loss of selfcontrol and compulsive drug taking behaviors, despite the intense desire to stop taking
the drugs (SAMHSA, 2017). Scientific evidence shows that disruptions in three areas of
the brain are particularly important in the onset, development, and maintenance of
substance use disorders: the basal ganglia, the extended amygdala, and the prefrontal
cortex (SAMHSA, 2017). These disruptions enable substance-associated cues to trigger
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substance seeking, reduce sensitivity of brain systems involved in the experience of
pleasure or reward, and heighten activation of brain stress systems and reduce
functioning of brain executive control systems, which are involved in the ability to make
decisions and regulate one’s actions, emotions, and impulses (Health Care Systems and
Substance Use Disorders, 2018).
Impaired Healthcare Professional
Multiple studies confirm the presence of substance abuse among anesthesia
providers. The term anesthesia provider includes: certified registered nurse anesthetist,
student registered nurse anesthetist, anesthesiologists, and anesthesiology residents.
Saunders (2006) revealed a lack of awareness of the actual systematic plan in place to
handle the problems of alcohol and drugs within hospitals. In more cases than not,
providers are not tested for drugs until they are reported by a co-worker for displaying
obvious signs and symptoms of impairment (Saunders, 2006). Shared risk factors for
anesthesia providers, in general, include easy access to narcotics, the stress of profession,
schedule irregularities, sleep deprivation, and requirement of absolute vigilance
overextended surgical procedures (Luck & Hedrick, 2004). A correlational study by Bell
et al. (1999) found that male CRNAs with 6-10 years of experience were at the highest
risk for substance abuse. High academic performance is also a risk factor as evidenced
by the top 10% of SRNAs showed higher addiction rate (Tetzlaff, 2011). According to
Tetzlaff (2011), the anesthesia work environment (e.g., the operating room) is ideal for
drug diversion and dependency. Bell et al. (1999) and Luck and Hedrick (2004) found
that versed and nitrous oxide are the two most commonly abused drugs among anesthesia
providers. On the contrary, Berge, Dillon, Sikkink, Taylor, and Lanier (2012) reported
18

that opioids are the most diverted drugs. Specifically, to opioids, Tetzlaff (2011) stated
fentanyl was the most abused opioid among anesthesia providers. According to AANA
(2016), the prevalence of anesthesia providers diverting drugs for self-administration is
9.8%.
The AANA (2015) highlights that knowledge of signs and behaviors of an
impaired provider is vital; however, the AANA also recognizes that identifying
impairment in a colleague is difficult. Difficulty in identifying impairment may be due to
the fact that these changes in behavior may not be abrupt. According to the AANA, as
cited in Luck and Hendrick (2004), these behavior changes may occur little by little, over
the course of months or years, making them complicated to identify. To make the
situation more difficult, impaired providers conceal their addiction in many different
ways. Addicts may alter their charting to show certain drugs were given, when in fact,
another drug was given, or sometimes, to the detriment of the patient, none were given at
all; some addicts may replace their drug of choice with another liquid, as if the drug had
never been tampered with at all (Bryson & Silverstein, 2008). Anita Bertrand, a Certified
Registered Nurse Anesthetist practicing in Houston, stated, “I was absolutely impaired,
using narcotics while working...And no one ever noticed;” she even placed an
intravenous port in her ankle for easier access to administer her drug of choice (Eisler,
2014., p. 1). Bertrand stated, “There are so many practitioners working impaired and we
have no idea...we’re doing a terrible job addressing this problem” (Eisler, 2014., p. 2).
Anesthesia providers have an in-depth knowledge of medications that give them
an advantage when choosing their drug of choice for abuse (Wright et al., 2012). Most of
the drugs chosen are difficult to detect due to short half-lives, making blood and urine
19

tests unreliable. There are multiple reasons why anesthesia providers divert drugs.
According to Tetzlaff (2011), the authors agree that previous drug experimentation is
associated with future substance abuse and has been confirmed by interviews of
recovering anesthesia providers. A majority of addicted anesthesia providers have a
novelty-seeking behavior and a history of personality disorders that lead to selfmedication and drug diversion (Tetzlaff, 2011).
As mentioned above, ineffective coping related to the stress of anesthesia school
can lead the student down a path of poor decision making and self-treatment. A study by
Perez and Carrol-Perez (1999) examined anesthesia students’ perception of stress. Of the
1,504 student responses, 73% reported their stress was categorized as a major life crisis
(Perez & Carrol-Perez, 1999). The statistics of substance abuse and drug diversion
among anesthesia professionals needs to be disclosed to the students in anesthesia
programs (Wright et al., 2012). Anesthesia students should be aware of the resources
available through the school or through professional organizations, so they may utilize
them if needed (Bozimowski et al., 2014). Students should be knowledgeable in drug
diverting signs and behaviors, so easy detection can be made (Bozimowski et al., 2014).
The guidelines SRNAs follow when drug diversion is suspected should be easily
accessible in the event the steps need to be followed (Bozimowski et al., 2014).
Prevention in the Workplace
Another common theme in the review of literature is the need for supplemental
education and policy development regarding substance abuse and drug diversion in
anesthesia providers. The AANA (2016) recommends the use of a thorough drug
diversion program and an unbiased substance abuse policy by healthcare institutions.
20

Within the drug diversion program, education to identify signs and behaviors of drug
diversion and steps to take if one suspects abuse should be of paramount importance.
However, the policy guidelines should be made clear to all employed staff and students
utilizing the facility for training purposes (AANA, 2016). There have been several
studies that have attempted to identify interventions to prevent or deter substance abuse
in anesthesia providers. Berge et al. (2012) examined drug diversion in multiple facilities
and the study included patterns, detection, and prevention of drug diversion.
Interventions included random drug sample processing of returned controlled substances,
automated drug distribution and return system and a more aggressive position of
prevention coordinators and committees. The authors did report an overall decline in
drug diversion, however, the data was limited, and no clear findings were indicated.
According to AANA (2016), a policy that builds awareness of individual risk factors
identifies signs and symptoms of substance abuse and utilizes drug diversion prevention
strategies, may discourage diversion and substance use while keeping patients and
providers safe.
By its nature, drug diversion is a clandestine activity, and methods in place in
many institutions leave cases undiscovered and unreported (Bell et al., 1999). The
review of the evidence suggests there needs to be ongoing efforts to prevent the diversion
of controlled substances from the workplace and to rapidly identify and respond when
such diversion is detected (Berge et al., 2012, p. 65). Healthcare facilities must have
systems in place to promptly identify drug diversion and intervene when it is occurring
(Berge et al., 2012). All healthcare workers must be vigilant for signs of diversion. It is
an accreditation requirement by the Council on Accreditation of Nurse Anesthesia
21

Educational Programs (COA) that all graduate and doctoral level nurse anesthesia
programs include the subject of substance abuse in their curriculum. The COA does not
lay out specific guidelines or tools for schools to follow to make sure consistent
education about substance abuse is being followed. However, the current literature does
put emphasis on the continuation of education on substance abuse after entry to
professional anesthesia practice. The AANA peer mentoring committee has provided
support for anesthesia providers struggling with addiction. Modules and current statistics
are available on the AANA website to all anesthesia providers, programs and
departments to utilize within their specialties as a means to provide education, show
support and prevent issues related to substance abuse. The resources provided on the
AANA website addressing substance abuse and drug diversion are made available, so
policy can be developed or improved.
Best Practice Guidelines
The AANA (2017) recommends facilities address the important element of patient
and provider safety through a comprehensive program and non-discriminatory policy
addressing substance use disorder. Substance use disorder should not be ignored. It can
result in harm to the impaired individual, their colleagues or patients. Regardless of the
substance abused, impairment on the job can adversely impact patient and provider safety
(Berge et al., 2012). Facility policy and education that address symptom awareness,
prevention, reporting, safe intervention, and reentry to the workplace, may minimize the
risk of substance diversion and minimize adverse outcomes (Berge et al., 2012). Policies
that advocate for fair and uniform management of providers with suspected or diagnosed
substance use disorder supports a safe environment for prompt reporting, appropriate
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treatment, and the possible reentry of the anesthesia professional into clinical practice
(Berge et al., 2012). According to the AANA, a policy that includes specific elements
are complying with best practice guidelines. These guidelines will aid in discouraging
drug diversion and substance abuse in the workplace, while also promoting the wellbeing of employees and patients. The elements are as listed below:
• Promotes healthy behaviors to support professional responsibility to be fit for
duty.
•

Builds awareness of individual risk factors.

•

Identifies behaviors and symptoms of substance use disorder and drug
diversion.

•

Acknowledges the harmful consequences of substance use disorder, drug
diversion, and impairment in the workplace.

•

Utilizes drug diversion prevention strategies.

•

Optimizes drug testing modalities (e.g., pre-employment, random, for-cause)
to include testing for anesthesia drugs.

• Outlines safe reporting processes of impaired individuals through the
appropriate chain of command.
•

Facilitates a safe intervention for appropriate treatment evaluation.

•

Addresses specific treatment considerations for anesthesia professionals.

•

Clarifies reporting obligations to authorities and/or licensing boards.

•

Maintains a safe, stigma-free workplace environment (AANA, 2016).
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Summary
Our nation is currently facing an opioid epidemic. It is the duty, not only to our
profession but to our patients to protect them from harm and provide the best quality care.
Impaired healthcare personnel places themselves, the patient, and the profession at risk.
Best practice guidelines suggest hospitals need to have clear policies set in place that
provide all healthcare employees with the steps to be taken when reporting drug
diversion. This DNP project was able to perform a policy analysis of a current drug
diversion policy at a hospital in southeast Mississippi. The policy analysis followed
Bardach’s model to policy analysis. After a thorough review of the literature, best
practice guidelines aided the student in analyzing the drug diversion policy. All eight
essential elements of the DNP degree were met in the development of this project.
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CHAPTER II - METHODOLOGY
Target Outcome
The outcome of this doctoral project was to perform a policy analysis of the drug
diversion policy at a healthcare facility located in southeast Mississippi. An executive
summary of suggested revisions to the current drug diversion policy was presented to key
stakeholders who could incorporate the suggested findings into the policy in the future.
Evidence gathered was not limited to anesthesia providers and SRNAs. Review of
evidence related to substance abuse in all healthcare professionals was also examined.
After a thorough review of the evidence, a set of best practice guidelines for the
facility’s’ drug diversion policy was established. As part of ongoing education, modules
were developed on drug diversion, signs and symptoms and the available resources if one
suspects abuse. It is a long-term goal of this project that the modules be required of not
only current CRNAs, but also the anesthesia students who utilize the hospital in southeast
Mississippi for clinical experience.
Sample
During the review of best practices, there were multiple populations studied. The
sample of this doctoral project was CRNAs and SRNAs who were either employed or
working in a hospital in southeast Mississippi. Other populations studied included
registered nurses, pharmacists, and medical residents.
Design
A policy analysis was performed on a drug diversion reporting and response
policy to detect the need for improvement of the process the facility utilizes. It was the
goal of this project to inform the local hospital of best practice guidelines and gaps in
25

current policy related to drug diversion. The outcomes management director at the
healthcare facility of interest was notified of the project and sent the current policy to the
DNP student. A SWOT analysis (Appendix D) was performed to weigh the benefits and
liabilities associated with the drug diversion policy. The SWOT analysis identified the
hospital's drug diversion policy’s strengths, weaknesses, opportunities, and threats to
revising or replacing the current policy. Evaluation of the gaps between the current
suggested best practice guidelines and the current policy at the local hospital was also
examined. Many types of data resources were explored including, suggested guidelines
for effective substance abuse policy, professional organizations, peer assistance resources
and other facilities with effective drug diversion and substance abuse policies in place.
The data resources also included state legislature, laws, and regulations on reporting
substance abuse among the anesthesia provider. The analysis of qualitative material was
an active and interactive process initiated with an exploration for wider classifications or
themes within the evidence. This qualitative approach was employed to thoughtfully
evaluate the drug diversion policy and compile suggested changes to be made to the
policy for the hospital of interest.
An executive summary of the findings, based on best practice guidelines and
input from the multidisciplinary team involved, was developed. After findings were
disseminated to key stakeholders, the student presented the key objectives of the project
to the anesthesia department along with an educational session on substance abuse and
drug diversion behaviors. The educational modules were developed with the goal of
introducing the disease of addiction and the impact it has on the anesthesia profession.
The modules aim to provide an effective and common grounding in drug diversion
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behaviors, how to report suspected drug diversion and the resources available to
providers in need. The design of the modules used an outcome-based approach. This
approach is defined as what can the “students,” and in this case anesthesia personnel and
anesthesia students, “do at the end of the modules.” The DNP student developed a draft
of the modules using PowerPoint Presentations. The modules were also shown to key
administrative and anesthesia-related participants. As part of ongoing education, it is a
long-term goal of this project that the modules be a requirement for anesthesia students
entering clinical for the first time. The presentation to administration and the anesthesia
department included an opportunity for feedback and comments
Barriers and Limitations
While planning this doctoral project, it was important to identify positive and
negative factors in implementing the overall project. Utilizing the SWOT analysis in the
early stages of planning, the student was able to identify the potential barriers and
facilitators to the clinical process change. The analysis revealed more strengths and
opportunities than threats or weaknesses to implementation. One strength includes the
shared interest between the DNP student, hospital administration, and anesthesia
department to improve processes and drug diversion policy guidelines. However,
barriers such as coworkers actually following policy and proper reporting process when
an anesthesia provider is suspected of drug diversion will need to be addressed.
According to Berge et al. (2012), most providers are not exactly sure how to address an
impaired provider or student and do not want to be part of the reason he/she loses their
job or license. Even though the best practice suggests the use of standardized policies
and procedures when dealing with these types of investigations, compliance from the
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employees within a department is key to carrying out these best practice guidelines
(Berge et al., 2012).
Ethical Considerations
The University of Southern Mississippi Institutional Review Board (IRB) granted
approval before the start of this project. IRB approval from the institution of interest was
not required due to the fact no human subjects are being studied. Participants, such as the
institution administration and research committee, were involved solely on a voluntary
basis. The DNP project was carried out following sound ethical principles. After the
policy analysis findings were disseminated to the participants, time for feedback was
encouraged as part of the evaluation of this DNP project. Feedback received from
participants was documented by the student. Participants were reassured all feedback and
suggestions for the future of the policy is kept confidential.
Summary
The outcome of this DNP project was to perform a policy analysis of a facility’s
drug diversion reporting and response policy. Suggested policy revisions were presented
to the key stakeholders and time was allotted for comments and feedback. A long-term
goal of this project included the use of the educational modules by the facility in the
future. This goal was met, and the facility of interest will be utilizing the modules in
their institution as they seem fit. The project faced limitations and anticipated potential
barriers without any lengthy setback. Sound ethical principles were carried out and
followed throughout the entire process of this DNP project.
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CHAPTER III – RESULTS
Discussion of Results
Seven of the 12 key stakeholders were present for the dissemination of the project
findings. Suggested areas to the current policy in need of change included financial
responsibilities, reporting to legal agencies and language specific to students using the
facility for clinical experience. After suggested changes to existing policy were
discussed with the key stakeholders at the institution of interest, time was allotted for
stakeholders to give their feedback, comments or concerns. Overall, the seven key
stakeholders were very receptive to the suggested policy changes presented. There was a
unanimous agreement regarding the policy needing specific language related to steps
taken when a SRNA is suspected and/or confirmed of drug diversion. It was discussed
that the facility would like to keep the language “simple”, if you will, in the sense it
should not be specific to each school program. The stakeholders had concerns when
addressing each school, each department and each type of program that uses their
facilities for clinical. It was decided that there definitely needs to be new language added
to the existing policy regarding clinical students (SRNAs, residents, physical therapy
students), but the language needs to be written cohesively with the universities already
existing drug diversion policies.
The educational modules were presented to stakeholders via PowerPoint
presentation and a copy were given to each one as well. Feedback from stakeholders
regarding the educational modules were positive. All participants voiced the need to
utilized modules throughout all departments at the facility. Permission was asked to
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utilize modules and statistics within. The student agreed to allow the facility of interest
to use the educational modules as they see fit for the future.
Summary
Seven of the 12 key stakeholders were present for the dissemination of policy
analysis findings. All stakeholders agreed that the current policy needs some revisions.
The facility of interest requested permission to use the projects research and education
modules as they see fit for their employees. Permission was granted by the student.
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CHAPTER IV – CONCLUSION
Implications for Future Practice
Policy analysis is an area of inexperience to most and the lack of research proves
this. The policy is the foundation of evidence-based practice. The policy is very
deliberate and guides decisions to achieve rational outcomes. Through policy, hospitals
around the world are able to provide patients with the best care possible. Better patient
outcomes drive policy decisions. As stated throughout this paper, drug diversion
reporting and response is an area of unfamiliarity. Future research needs to be aimed at
creating guidelines on how institutions should perform a policy analysis and how to
implement the findings from the analysis into practice. Research in the future should
explore the effectiveness of continual drug diversion and wellness education programs
already implemented at healthcare facilities.
Interpretation of Results
The purpose of this DNP project was to perform a policy analysis on a drug
diversion reporting and response policy. The review of literature and the best practice
guidelines aided in the analysis of the facilities drug diversion policy. Although, only 7
of the 12 key stakeholders were present at the dissemination of the policy analysis, the
overall impact the projects findings had were positive. Evaluation of the project was
based off the feedback given by the key stakeholders. All parties involved agreed
changes needed to be made to existing policy in order to meet the best practice guidelines
for an effective drug diversion policy. Permission granted by stakeholders to use the
educational modules and all evidence-based research gathered to educate their staff on
drug diversion in the future.
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Limitations
The project had several limitations which put into question the generalizability of
the policy analysis findings. The stakeholders present were members of research and
quality improvement departments. Therefore, the results of the policy analysis were not
presented to other pertinent departments, such as pharmacy and anesthesia. The
procedures and policies used for the operating room are different, if you will, when
compared to other areas of the hospital. This difference is due to the types of drugs being
used on a daily basis by anesthesia providers. Effort was made to account for this
limitation by emailing the chief anesthesiologist results of the drug diversion policy
analysis and the suggested revision. Also, personal bias of the DNP student and
involvement as a student registered nurse anesthetist was a factor that could limit the
internal validity of the project. Acknowledging this personal bias ahead of time, the
student was able to not only focus on anesthesia providers and drug diversion but to
allow all types of healthcare providers be addressed.
Conclusion
Countless patients are put at risk of receiving substandard care by impaired
healthcare personnel. This poses very real implications for patient safety and should not
go unnoticed. Limiting the misuse and drug diversion of prescription drugs requires a
coordinated approach between regulatory bodies, hospital administrations, pharmacy and
individual health care providers. The purpose of this DNP project was to perform a
policy analysis on the drug diversion reporting and response policy at the institution of
interest. The policy analysis revealed a gap in the institution's language specifically to
students utilizing the facility of interest for a clinical site. The subtle discrepancies found
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between the institution’s drug diversion policy and the best practice guidelines for such a
policy were disseminated to the key stakeholders. There was a unanimous decision by
the participants that felt their institution's policy exhibited the need for revision and that
this revision would be beneficial for the institution, therefore ensuring the safety of their
patients.
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APPENDIX A – Literature Matrix

AUTHOR/YEAR/TITLE

DESIGN

SAMPLE/DATA

FINDINGS

RECOMMENDATIONS

Bell, McDonough, Ellison,
& Fitzhugh, (1999).
Controlled drug misuse by
certified registered nurse
anesthetists

A correlational
study using selfadministered
surveys to collect
data

2,500 subjects were
randomly selected
from actively
practicing members
of AANA. Of these,
1,709 completed the
survey with a
response rate of
68.4%

9.8% prevalence
of controlled drug
misuse among
CRNAS
Male CRNA 6-10
years of
experience have
increased risk for
drug misuse

Addiction education should be
mandatory in anesthesia
schools; most CRNAs feel
their colleagues who
successfully complete rehab
should be permitted to re-enter
the profession; however, after
a relapse, most believe reentry should be denied

Berge, Dillon, Sikkink,
Taylor & Lanier. (2012)
Diversion of drugs within
healthcare facilities, a
multiple victim crime:
Patterns of diversion,
scope, consequences,
detection, and prevention

Institution-wide
Mayo Clinic
Quality
Improvement
Effort

Approximately
75% of suspected
drug diversion has
been resolved
through
confession of the
drug diverter

Bozimowski, Groh, Rouen
& Dosch, (2012). The
prevalence and patterns of
substance abuse among
nurse anesthesia students

Cross-sectional,
retrospective
study using
electronic survey

Entire Mayo
Healthcare system.
Began in the
anesthesia
department in the
OR and expanded
throughout other
departments with
high use of
controlled
substances.
Program directors of
111 accredited nurse
anesthesia programs
in the United States
received the
electronic survey.
Of these, 23 PDs
(21.7 % response
rate) have complete
data on prevalence
and demographics
and additional 24
PDs (42.3%
response rate)
completed questions
related to screening
procedure and
prevention strategies
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Prevalence of
substance abuse
was lower among
SRNAs (0.65%)
than CRNAs
(9.8%), but the
comparison is
based on historical
data. Opiate is the
top drug of choice
for SRNAs.
Voluntary
enrollment to
treatment
and dismissal
from the program
were the top
reported outcomes
of substance
abuse. Drug
testing for cause
during the
program was the
top reported
screening
procedure
Wellness
activities,
educational
offerings and
faculty support
were among other
themes.

Future studies need to identify
the effectiveness of wellness
and prevention strategies, so
anesthesia programs could be
more proactive in promoting
wellness, effective screening
in their students as they
transition from student to
practitioner.

Authors suggest further
research is necessary to
confirm.

AUTHOR/YEAR/TITLE

DESIGN

SAMPLE/DATA

FINDINGS

Luck & Hendrick, (2004)
The alarming trend of
substance abuse in
anesthesia providers

Descriptive
literature review

NA

Estimates of
Addiction among
anesthesia providers
are as high as 15%.
Midazolam and
Nitrous Oxide are
currently the drugs
of choice for
addicted anesthesia
providers.

Tetzlaff, (2011). Drug
diversion, chemical
dependence, and
anesthesiology.

Descriptive
literature review

Tetzlaff, Collins, Brown,
Leak, Pollock & Popa.
(2010). A strategy to
prevent substance abuse in
an academic
anesthesiology department.

Quality
Improvement

RECOMMENDATIONS

Estimates of
Addiction among
anesthesia
dependency and the
multiple factors that
may lead to this.

The Cleveland
Clinic's
Anesthesiology
Institute
approached the
process from the
perspective of
active prevention,
including specific
mandatory
education
programs for all
department
personnel on a
recurring basis,
strengthened
procedures for the
detection and
prevention of
diversion of
controlled
substances,
enhanced skill
building for
detection of
impairment, and
implemented a
multi-faceted drug
testing program,
including random
and "for cause"
urine screens, for
prevention and
early detection of
abused anesthetic
drugs and other
substances of
abuse.
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After 18 months of
preparation, a Substance
Abuse Prevention Protocol
was created, which has been
fully implemented as of
September 1, 2007.

AUTHOR/YEAR/TITLE

DESIGN

SAMPLE/DATA

FINDINGS

Warner, Schaefer, Patel,
Drobeniuc, Xia, Lin &
Thompson. (2015). The
outbreak of hepatitis C
virus infection associated
with narcotics diversion by
a hepatitis C virus-infected
surgical technician

Observational,
epidemiological
case finding and
report

Facility A: Total
Patients N=4748
Patients tested
N=4066

18 confirmed cases
of HCV from the
surgical tech that
diverted fentanyl
from the anesthesia
carts in the
OR. Limitations
include test results
were not received
from 674 patients.

Wright, McGuiness,
Moneyham, Schumacher,
Zwerling & Stullengarger,
(2012).
“Opioid abuse among
nurse anesthetists and
anesthesiologists.”

Qualitative
Inquiry

Facility B: Total
Patients N=1222
Patients tested
N=1183 HCV
infected surgical
technician who
was suspected of
narcotic drug
diversion and
tampering of
injectable
narcotic, exposing
patients to his
HCV infected
blood.
NA
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This article reviews
the literature
regarding opioid
abuse and
dependency among
nurse anesthetist
and
anesthesiologists.

RECOMMENDATIONS

More studies need to be
conducted on the presence of
these predisposing risk factors
and how it influences the
development of actual
substance abuse during their
careers. Results could
provide the foundation for a
standardized approach
amongst anesthesia programs.

APPENDIX B - Key Fact Sheet
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APPENDIX C – Policy Analysis
Current Best
Practice Guidelines

The Hospitals Drug
Diversion/Reporting
Policy

Maintain clear and
concise steps for
employees/supervisors
to follow when
reporting drug
diversion in student

Does not have
language regarding
supervisors’ steps to
take in contacting the
university if a student
is suspected
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The
University’s
Impaired
Student
Policy
States
“program
director,
department
chair and
associate dean
will be
notified”
“the faculty
member will
confront the
student with
the behavior
observed”

Recommended
updates/edits to the
hospital’s existing
protocol
“if an FGH fellow,
resident, medical
student (include any
type of learner) is
suspected of
diverting drugs
within the scope of
their training by the
Committee D at
FGH/Designated
Nurses, the point of
the program of
contact
administrator should
be notified.
(language needs to
be specific for each
program utilizing
FGH as a clinical
site).
If a USM SRNA is
suspected of
diverting drugs
within the scope of
their training, the
USM NAP Program
administrator will
be notified
immediately and
any further contact
deemed necessary
will be done so by
the program
administrator.

Financial
Responsibility of
hospital

No guidelines exist

“the faculty
member will
request an
alcohol or
drug screen.
The CON will
assume the
cost of the
alcohol or
drug screen”

What to do with the
student once a drug
test is done, etc

No guidelines exist

“the student
will be
immediately
suspended
from the
nursing
program (not
from the
University)
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Add language to
current policy
stating the program
administrator will
be notified of a
student suspected
and/or confirmed
behavior and
financial
obligations, such as
drug testing fees,
will be covered by
the CONHP
(College of nursing
and health
professionals), as
stated in USM’s
impaired nursing
student policy.
Add Language
addressing the
hospitals
responsibility once a
student has tested
positive or denied
drug test. Suggested
language is as
follows: If an FGH
resident or medical
student admits
substance abuse and
tests positive, policy
guidelines as stated
in the specific
program's policy
will be followed. An
employee will
remain with the
student until a
program
administrator or
designated person
arrives (will need to
include a specific

person of contact for
other programs)

Reporting to law
enforcement, licensing
boards, and other
government agencies

“drug diversion by an
employee will be
reported to all
appropriate
government,
licensing, regulatory
and law enforcement
agencies”
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Lacks clear
guidelines

If a USM nurse
anesthesia student
admits to substance,
test positive or
denies drug screen
test, the USM NAP
administrator will
be notified
immediately. An
employee will
remain with the
SRNA until NAP
administrator or
designated person
arrives. The USM
NAP program
administrator or
representative will
then allow the
student to be
released to a
responsible adult.
Recommendations
also include
language stating that
suspected and/or
confirmed impaired
provider should not
be allowed to
operate a vehicle.
Suggested change in
language: “Any
follow-up and/or
further reporting,
such as notifying
Board of Nursing or
police department
will be decided by
the FGH Committee
D/Designated nurses
and The USM NAP
Administrator”.

APPENDIX D- SWOT Analysis

Strengths
•
•
•

Weaknesses
•

No cost to the institution
Comprehensive policy analysis
Administration and anesthesia
department support of the
project

•
•

Opportunities
•
•

•

To provide a safe and
confidential process for
reporting drug diversion
Fewer adverse event associated
with an impaired employee

•
•
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Compliance from health care
employees to follow policy
guidelines
Bias criticism from different
departments and their views on
policy
Associated guilt/fear with
reporting an employee
Threats
Resistance to change by all
employees
Resistance to change and/or
disinterest by administration
and university
Employees not reporting due to
fear of a breach in
confidentiality

APPENDIX E– Letters of Support
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APPENDIX F– Educational Modules
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APPENDIX G– IRB Approval Letter
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